AVIR FY 2022 Earnings — Atea Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AVIRAtea Pharmaceuticals, Inc.

$501M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$62M

Operating Income

-$131M

Net Income

-$116M

EPS (Diluted)

$-1.39

Cash Flow

Operating Cash Flow

-$121M

Free Cash Flow

-$123M

Stock-Based Comp.

$47M

Balance Sheet

Total Assets

$667M

Total Liabilities

$26M

Stockholders' Equity

$641M

Cash & Equivalents

$647M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$351M	-100.0%
Gross Profit	-$62M	$184M	-133.9%
Operating Income	-$131M	$138M	-194.4%
Net Income	-$116M	$121M	-195.6%